Gland Pharma Ltd is hosting a Mega Apprentice Walk-In Drive in Visakhapatnam as part of the National Apprenticeship Promotion Scheme (NAPS), aimed at fresh graduates eager to embark on a career in the regulated injectable manufacturing sector. This initiative is particularly suited for individuals seeking practical industry experience, structured training, and a solid grounding in pharmaceutical operations, with selected apprentices being assigned to various production roles at Gland Pharma’s facilities. Candidates eligible for this opportunity must possess an ITI, Diploma, or B.Sc in Chemistry, having graduated in the years 2022, 2023, 2024, 2025, or 2026, and should be freshers not currently enrolled under ESIC or EPF. The apprenticeship lasts for one year and applicants should be prepared to work in shifts. The walk-in interviews are scheduled for October 14th, 15th, and 16th, 2026, from 9:30 AM to 11:30 AM at Gland Pharma Ltd, located in Duvvada, Visakhapatnam.
Vacancy details
Department: Production
Role: Apprentice
Experience: Freshers
Apprenticeship Duration: 1 Year
Eligibility Criteria
Qualification: ITI/ Diploma/ B.Sc. (Chemistry)
Year of Passing: 2022, 2023, 2024, 2025 &2026
Experience: Freshers only
Not enrolled under ESIC / EPF
Preferable required to work in shifts.
Stipend: Stipend determined by the candidate’s qualifications
Walk-In interview Details
Date of interview: 14th, 15th & 16th October 2026
Time: 09:30 AM – 11:30 AM
Work Location & Interview Venue: GLAND PHARMA LIMITED, Block C, Phase 1, Duvvada, Visakhapatnam, Andhra Pradesh – 530046.
Documents Required (Mandatory)
Candidates are required to bring an updated resume, educational certificates, copies of Aadhaar and PAN, bank account details, and a signed photograph.
Disclaimer: It is important to note that Gland Pharma does not request any payment from candidates for employment opportunities.
About Gland Pharma Limited
Gland Pharma, founded in Hyderabad, India in 1978, has evolved from a contract manufacturer of small volume liquid parenteral products into one of the largest and fastest-growing companies in the generic injectables sector, boasting a presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily on a business-to-business (B2B) model, the company has established a strong reputation in pharmaceutical research and development, as well as in the manufacturing and marketing of complex injectables. This comprehensive engagement across the value chain has facilitated significant growth. The company is supported by a professional management team, with one of its promoters, Shanghai Fosun Pharma, being a prominent player in the global pharmaceutical industry.